Gadopentetate Peptide Conjugates

Gadopentetate peptide conjugates consist of the gadolinium-based contrast agent gadopentetate dimeglumine chemically linked to targeting peptides designed to bind specific tissue markers or receptors. These hybrid molecules combine the MRI contrast properties of chelated gadolinium with the molecular specificity of peptides to enable targeted imaging of tumors, inflammatory lesions, or vascular pathology.

Various peptide motifs including RGD sequences and somatostatin analogs have been conjugated to gadolinium chelates for preclinical evaluation..

Gadopentetate Peptide Conjugates is in the research phase with limited clinical data in humans. Current evidence is primarily derived from preclinical (animal or in vitro) studies.